Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment

被引:74
作者
Aleksunes, Lauren M. [1 ]
Augustine, Lisa M. [2 ]
Scheffer, George L. [3 ]
Cherrington, Nathan J. [2 ]
Manautou, Jose E. [1 ]
机构
[1] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA
[2] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA
[3] VU Med Ctr, Dept Pathol, NL-1081 HV Amsterdam, Netherlands
基金
美国国家卫生研究院;
关键词
transporters; cisplatin; kidney; toxicity;
D O I
10.1016/j.tox.2008.06.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The goal of this study was to identify alterations in mRNA and protein expression of various xenobiotic transport proteins in mouse kidney during cisplatin-induced acute renal failure. For this purpose, male C57BL/6J mice received a single dose of cisplatin (18 mg/kg, i.p.) or vehicle. Four days later, tissues were collected for assessment of plasma BUN, histo pathological analysis of renal lesions, and mRNA and Western blot analysis of renal transporters including organic anion and cation transporters (Oat, Oct), organic anion transporting polypeptides (Oatp), multidrug resistance-associated proteins (Mrp), multidrug resistance proteins (Mdr), breast cancer resistance protein (Bcrp) and multidrug and toxin extrusion proteins (Mate). Cisplatin treatment caused necrosis of renal proximal tubules along with elevated plasma BUN and renal kidney injury molecule-1 mRNA expression. Cisplatin-induced renal injury increased mRNA and protein levels of the efflux transporters Mrp2, Mrp4, Mrp5, Mdr1a and Mdr1b. Uptake transporters Oatp2al and Oatp2b1 mRNA were also up-regulated following cisplatin. By contrast, expression of Oat1, Oat2, Oct2 and Oatp1a1 mRNA was reduced in cisplatin-treated mice. Expression of several uptake and efflux transporters was unchanged in cisplatin-treated mice. Apical staining of Mrp2 and Mrp4 proteins was enhanced in proximal tubules from cisplatin-treated mice. Collectively, these expression patterns suggest Coordinated regulation of uptake and efflux pathways during cisplatin-induced renal injury. Reduced expression of basolateral and apical uptake transporters along with enhanced transcription of export transporters likely represents an adaptation to lower intracellular accumulation of chemicals, prevent their reabsorption and enhance urinary clearance. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:82 / 88
页数:7
相关论文
共 33 条
  • [11] DOBYAN DC, 1980, J PHARMACOL EXP THER, V213, P551
  • [12] Assessment of cisplatin-induced nephrotoxicity by microarray technology
    Huang, Q
    Dunn, RT
    Jayadev, S
    DiSorbo, O
    Pack, FD
    Farr, SB
    Stoll, RE
    Blanchard, KT
    [J]. TOXICOLOGICAL SCIENCES, 2001, 63 (02) : 196 - 207
  • [13] ISHIKAWA T, 1993, J BIOL CHEM, V268, P20116
  • [14] The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides
    Jedlitschky, G
    Burchell, B
    Keppler, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (39) : 30069 - 30074
  • [15] Multidrug resistance-associated protein2 (MRP2) plays an important role in the biliary excretion of glutathione conjugates of 4-hydroxynonenal
    Ji, B
    Ito, K
    Suzuki, H
    Sugiyama, Y
    Horie, T
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 (03) : 370 - 378
  • [16] Localization of organic cation transporters OCT1 and OCT2 in rat kidney
    Karbach, U
    Kricke, J
    Meyer-Wentrup, F
    Gorboulev, V
    Volk, C
    Loffing-Cueni, D
    Kaissling, B
    Bachmann, S
    Koepsell, H
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 279 (04) : F679 - F687
  • [17] KLAASSEN CD, TOXICOL SCI, V103, P35
  • [18] Kool M, 1997, CANCER RES, V57, P3537
  • [19] Protection of platinum-DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells
    Materna, V
    Liedert, B
    Thomale, J
    Lage, H
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 115 (03) : 393 - 402
  • [20] RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells
    Materna, Verena
    Stege, Alexandra
    Surowiak, Pawel
    Priebsch, Axel
    Lage, Hermann
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 348 (01) : 153 - 157